Four-Year Haalbaarheid and Veiligheid Resultaten of a Phase 1/2 Single-Arm Prospectieve Klinische trial of Stereotactic Magnetic Resonance-Guided Adaptive Radiotherapie for Metachronous Oligogemetastaseerd Abdominopelvic Lymfeklier and Soft Tissue Metastases
Metachronous oligometastases may represent a favorable disease state for local therapy after prior curative treatment.
Abstract (original)
Metachronous oligometastases may represent a favorable disease state for local therapy after prior curative treatment. Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy (SMART) provides precise targeting of nodal and soft tissue metastases. The primary objective was to assess the feasibility and safety of SMART for abdominopelvic metachronous oligometastases. Secondary objectives included assessing rates of toxicities and evaluating local control (LC).
Dit artikel is een samenvatting van een publicatie in Int J Radiation Oncology. Voor het volledige artikel, alle details en referenties verwijzen wij u naar de oorspronkelijke bron.
Lees het volledige artikelDOI: 10.1016/j.ijrobp.2026.01.002